Markets extend rally for 4th straight day; Sensex jumps 150 points, Nifty defends 17500
Indian shares ended trade with gains but off from Wednesday's highs as investors took to profit-booking at higher levels. The benchmark 30-share BSE Sensex closed at 59,107, rising 146 points, while the broader 50-share NSE Nifty50 held the crucial 17,500 support, ending at 17,512 with a 25 points gain. Indices were supported by buying in oil and gas, financial services and FMCG stocks while selling in IT, metal and PSU bank stocks offset the gains. Among shares, Nestle India, ITC and HDFC Ltd were top gainers, while JSW Steel, NTPC, Bajaj Finserv and SBI were among the top laggards on Nifty. Among sectors, oil and gas and FMCG surged the most while IT and metal ended in the red. Broader markets also had a volatile session with Nifty Midcap 100 and Smallcap 100 settling with a quarter per cent gains. Meanwhile, the Indian Rupee plunged by 61 paise to dip below 83 mark for the first time. It closed at a record low of 83.01 (provisional) against the US dollar.
Indian shares ended trade with gains but off from Wednesday's highs as investors took to profit-booking at higher levels. The benchmark 30-share BSE Sensex closed at 59,107, rising 146 points, while the broader 50-share NSE Nifty50 held the crucial 17,500 support, ending at 17,512 with a 25 points gain. Indices were supported by buying in oil and gas, financial services and FMCG stocks while selling in IT, metal and PSU bank stocks offset the gains. Among shares, Nestle India, ITC and HDFC Ltd were top gainers, while JSW Steel, NTPC, Bajaj Finserv and SBI were among the top laggards on Nifty. Among sectors, oil and gas and FMCG surged the most while IT and metal ended in the red. Broader markets also had a volatile session with Nifty Midcap 100 and Smallcap 100 settling with a quarter per cent gains. Meanwhile, the Indian Rupee plunged by 61 paise to dip below 83 mark for the first time. It closed at a record low of 83.01 (provisional) against the US dollar.
Latest Updates
UltraTech Result
Aditya Birla group firm UltraTech Cement Ltd on Wednesday reported a decline of 42.09 per cent in its consolidated net profit at Rs 758.70 crore for the second quarter ended on September 30, 2022. The company had posted a net profit of Rs 1,310.34 crore in the July-September period a year ago, UltraTech Cement said in a BSE filing. Its revenue from operations rose 15.61 per cent to Rs 13,892.69 crore during the quarter under review as against Rs 12,016.78 crore in the corresponding period of the last fiscal.
Sebi focuses on data, technology tools to detect malpractice in market
With an aim to strengthen transparency and fairness in the capital markets, Sebi is focusing on data tools to detect wrong-doing in the securities market as well as for its policy formulation. Apart from data, another focus area for the Securities and Exchange Board of India (Sebi) would be deployment of technology. "Data and technology are the two new tools that Sebi is building for itself," the regulator said, adding that the move would enhance transparency and fairness in the securities market.
Nifty Smallcap +0.20%
Nifty midcap +0.15%
Logistic Gainers
Aegis Logistics +6%
Allcargo Logistic +4%
Delhivery +1.20%
Education Gainers
Navneet Edu +6%
Kokuyo Camlin +4%
S Chand & CO + 1.5%
Housing Finance Gainers
REPCO HOMES +5.2%
PNB Housing +5%
IB Housing Fin +2.50%
Home First +2%
Midcap IT Losers
KPIT TECH -5.2%
Intellect design -1.50%
Cyient -1.50%
Auto Ancillary Losers
Bharat Gears -6%
NRB Bearing -2.2%
India Nippon Electricals -2%
Chemical Losers
Camlin Fine Science -3%
Tanfac Ind -2.6%
Kanoria Chemicals -2.5%
DCW Ltd -1.70%
Nestle India Q3 Results
FMCG major Nestle India on Wednesday said that its September quarter profit increased 8.3 per cent YoY to Rs 668 crore, beating the estimates. The quarterly revenue increased 18.3 per cent YoY to Rs 4,591 crore, according to an exchange filing by the company. READ MORE
Piramal Pharma shares to list on NSE, BSE today after demerger: Check expected listing price
According to Zee Business analyst Nupur, Piramal Pharma share listing price could be around 200-250. READ MORE